玻璃化市场、机会、成长动力、产业趋势分析与预测，2024-2032

Vitrification Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月10日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在不孕率不断上升的推动下，玻璃化冷冻市场规模从 2024 年到 2032 年的复合年增长率预计将达到 10.1%。玻璃化冷冻是保存胚胎和卵母细胞的关键技术，可以保护那些面临生育问题的人的生殖选择。为了满足生育治疗不断增长的需求，研究人员和临床医生正在对玻璃化冷冻过程进行微调。这些增强功能不仅提高了生育手术的成功率，也为面临不孕症挑战的个人提供了强而有力的支持。根据世界卫生组织最近的报告，全球约有六分之一的人患有不孕症。这种上升趋势正在推动玻璃化冷冻方法的采用，旨在提高辅助生殖治疗的成功率。

玻璃化产业分为产品类型、样本、最终用途和地区。

试剂盒产品类型细分市场的市场份额将在2024 年至2032 年间录得可观的增长率。。这种快速冷却可以最大限度地减少冰的形成，而冰的形成是细胞和组织活力的关键因素。玻璃化试剂盒在干细胞储存和胚胎保存等应用中也发挥关键作用，可微调冷却速率和配方以提高保存成功率。

就标本而言，预计 2024 年至 2032 年胚胎玻璃化市场将出现显着的复合年增长率。这种生长是由保存胚胎、抑製冰晶形成和潜在细胞损伤的必要性所驱动的。随着玻璃化冷冻方案的不断完善，研究人员的目标是提高胚胎保存和植入的成功率。这些进步有望提供更有效、更可靠的胚胎保存方法，与生育治疗和生殖健康的发展保持一致。

由于政府措施和资金的增加，到 2032 年，亚太地区玻璃化产业规模将创下显着的复合年增长率。许多政府都支持冷冻保存技术研究，包括玻璃化冷冻，以促进生育治疗和生殖健康。这些措施旨在利用财政援助和资源来提高技术及其成功率。这种坚定不移的支持凸显了玻璃化冷冻在推动亚太地区生殖保健方面的关键作用。

产业生态系统分析
产业影响力
- 成长动力
  - 生育治疗的需求不断增加
  - 扩大生物样本库领域
  - 对体外受精的认识与接受度不断提高
  - 冷冻保存技术的进步
- 产业陷阱与挑战
  - 玻璃化冷冻过程成本高
  - 严格的监管要求
成长潜力分析
监管环境
定价分析
未来市场趋势
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

主要趋势
装置
- 开放系统
- 封闭系统
套件
试剂及耗材

第 6 章：市场估计与预测：按样本，2021 - 2032

主要趋势
胚胎
卵母细胞
精子

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
体外受精诊所
生物样本库

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Biotech, Inc.
CooperSurgical Fertility Company
FERTIPRO NV
FUJIFILM Irvine Scientific
Genea BIOMEDX
IMV Technologies Group (Cryo Bio System)
Kitazato Corporation.
MFC Global
MINITUB GMBH
NidaCon International AB
Optimas
Shenzhen VitaVitro Biotech
Vitrolife

简介目录

Product Code: 10188

Vitrification Market size is set to record a 10.1% CAGR from 2024 to 2032 driven by escalating infertility rates. Vitrification serves as a pivotal technique for preserving embryos and oocytes for safeguarding reproductive choices for those grappling with fertility issues. In response to the surging demand for fertility treatments, researchers and clinicians are fine-tuning the vitrification process. These enhancements not only bolster the success rates of fertility procedures but also offer robust support to individuals facing infertility challenges. According to a recent WHO report, approximately 1 in 6 individuals globally contend with infertility. This rising trend is propelling the adoption of vitrification methods, aiming to boost success rates in assisted reproductive treatments.

The vitrification industry is segmented into product type, specimen, end-use, and region.

The market share from the kits product type segment will record a decent growth rate between 2024 and 2032. This surge is attributed to the increasing demand for biological sample preservation, achieved by swiftly cooling samples to a glass-like state. Such rapid cooling minimizes ice formation, a crucial factor for the viability of cells and tissues. Vitrification kits also play a pivotal role in applications like stem cell storage and embryo preservation for fine-tuning cooling rates and formulations to enhance preservation success rates.

In terms of specimen, the vitrification market from the embryos segment is anticipated to witness a significant CAGR from 2024-2032. This growth is driven by the imperative to preserve embryos, curbing ice crystal formation and potential cell damage. With ongoing refinements in vitrification protocols, researchers aim to boost embryo preservation and implantation success rates. These advancements promise more effective and dependable embryo preservation methods, aligning with the evolution of fertility treatments and reproductive health.

Asia Pacific vitrification industry size will record a significant CAGR through 2032 due to rising government initiatives and funding. Numerous governments are backing cryopreservation technology research, including vitrification, to bolster fertility treatments and reproductive health. With financial assistance and resources at their disposal, these initiatives aim to elevate technology and its success rates. Such unwavering support underscores the pivotal role of vitrification in advancing reproductive healthcare in APAC.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for fertility treatment
  - 3.2.1.2 Expanding biobanking sector
  - 3.2.1.3 Rising awareness and acceptance of IVF
  - 3.2.1.4 Advancements in cryopreservation technologies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of vitrification procedure
  - 3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Devices
- 5.2.1 Open system
- 5.2.2 Closed system
5.3 Kits
5.4 Reagents and consumables

Chapter 6 Market Estimates and Forecast, By Specimen, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Embryos
6.3 Oocytes
6.4 Sperms

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 In vitro fertilization clinics
7.3 Biobanks

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 The Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa